Aligos Therapeutics logo

Aligos Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

Aligos Therapeutics is a clinical-stage biotechnology company focused on therapies for liver and viral diseases. Its pipeline targets chronic hepatitis B virus infection, metabolic dysfunction-associated steatohepatitis, obesity, and coronaviruses, reflecting a science-driven approach to addressing high unmet medical needs. Based in South San Francisco, California, the company is a mid-sized organization advancing research into therapies aimed at improving patient outcomes.

A recent development sees the company enter into an exclusive license agreement with Xiamen Amoytop Biotech to develop pevifoscorvir sodium in Greater China for chronic hepatitis B infection. The arrangement highlights ongoing efforts to advance its hepatitis B program and broaden its geographic footprint through partnerships.

Find Aligos Therapeutics employees' phone numbers or email addresses

Aligos Therapeutics Global Highlights

Location
Employees

North America
84

Minus sign iconPlus sign icon
  • United States Of America
    84

Europe
18

Minus sign iconPlus sign icon
  • Belgium
    15
  • Ireland
    1
  • Spain
    1
  • Greece
    1

Asia
4

Minus sign iconPlus sign icon
  • China
    2
  • Iran
    1
  • Lebanon
    1

Aligos Therapeutics's Leadership

  • Stylized image of a person
    T. L.
    Vp Clinical Development
  • Stylized image of a person
    T. L.
    Senior Vice President Of Clinical Development
  • Stylized image of a person
    K. W.
    Vice President, Head Of Cmc
  • Stylized image of a person
    N. N. M.
    Sr. Director - Drug Product Development
  • Stylized image of a person
    B. M.
    Senior Director, Clinical Development
  • Stylized image of a person
    D. M.
    Director Medicinal Chemistry
  • Stylized image of a person
    V. S.
    Director - Process Chemistry
  • Stylized image of a person
    I. K.
    Director, Clinical Operations

Aligos Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Consultant
  • Engineering
  • Finance
  • Other
  • Biotechnology
  • Human Resources
  • Business
  • Sales
  • Accounting

Contact profiles from Aligos Therapeutics

Name
Title
Contact
Location
Last Update
  • Stylized image of a person
    T. W.
    Executive Director -Medchem & Project Leader
    BelgiumFlanders
    Apr 16, 2026
  • Stylized image of a person
    D. D. L.
    Vice President, Head Of It And Cybersecurity
    Bay
    Jul 30, 2026

Frequently Asked Questions

What is Aligos Therapeutics known for?

Minus sign iconPlus sign icon
Aligos Therapeutics was founded in 2018 operates in the Biotechnology Research industry. Explore Aligos Therapeutics's company overview page for more information.

What is Aligos Therapeutics's most common email format?

Minus sign iconPlus sign icon
Aligos Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Aligos Therapeutics email formats with LeadIQ.

How many employees does Aligos Therapeutics have currently?

Minus sign iconPlus sign icon
Aligos Therapeutics has approximately 96 employees as of July 2026. These team members are located across 3 continents, including North AmericaEuropeAsia.

Who are Aligos Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Aligos Therapeutics's key employees include:

  • Vp Clinical Development: T. L.
  • Senior Vice President Of Clinical Development: T. L.
  • Vice President, Head Of Cmc: K. W.
  • Sr. Director - Drug Product Development: N. N. M.
  • Senior Director, Clinical Development: B. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.